Correction to: Clinical implications of AGBL2 expression and its inhibitor latexin in breast cancer.
作者信息
Zhang Hao, Ren Yuan, Pang Deyan, Liu Caigang
机构信息
Department of Breast Surgery, Second hospital of Dalian Medical University, Zhongshan Road, Dalian, 116023, People's Republic of China.
Department of Hematology, First hospital of China Medical University, Nanjing Street, Shenyang, 110001, People's Republic of China.
出版信息
World J Surg Oncol. 2025 May 14;23(1):191. doi: 10.1186/s12957-025-03831-0.
Abstract
摘要
相似文献
1
Correction to: Clinical implications of AGBL2 expression and its inhibitor latexin in breast cancer.
World J Surg Oncol. 2025 May 14;23(1):191. doi: 10.1186/s12957-025-03831-0.
2
Clinical implications of AGBL2 expression and its inhibitor latexin in breast cancer.AGBL2表达及其抑制剂latexin在乳腺癌中的临床意义。
World J Surg Oncol. 2014 May 7;12:142. doi: 10.1186/1477-7819-12-142.
3
Effects of AGBL2 on cell proliferation and chemotherapy resistance of gastric cancer.AGBL2对胃癌细胞增殖及化疗耐药性的影响。
Hepatogastroenterology. 2015 Mar-Apr;62(138):497-502.
4
AGBL2 promotes renal cell carcinoma cells proliferation and migration via α-tubulin detyrosination.AGBL2通过α-微管蛋白去酪氨酸化促进肾癌细胞增殖和迁移。
Heliyon. 2024 Sep 4;10(18):e37086. doi: 10.1016/j.heliyon.2024.e37086. eCollection 2024 Sep 30.
5
High expression of AGBL2 is a novel prognostic factor of adverse outcome in patients with ovarian carcinoma.AGBL2的高表达是卵巢癌患者不良预后的一个新的预后因素。
Oncol Lett. 2019 Nov;18(5):4900-4906. doi: 10.3892/ol.2019.10829. Epub 2019 Sep 9.
6
AGBL2 promotes cancer cell growth through IRGM-regulated autophagy and enhanced Aurora A activity in hepatocellular carcinoma.AGBL2 通过 IRGM 调控的自噬和增强肝癌细胞中的 Aurora A 活性促进癌细胞生长。
Cancer Lett. 2018 Feb 1;414:71-80. doi: 10.1016/j.canlet.2017.11.003. Epub 2017 Nov 8.
7
Mechanistic insights into HuR inhibitor MS-444 arresting embryonic development revealed by low-input RNA-seq and STORM.通过低输入RNA测序和STORM揭示HuR抑制剂MS-444阻断胚胎发育的机制性见解
Cell Biol Toxicol. 2022 Dec;38(6):1175-1197. doi: 10.1007/s10565-022-09757-7. Epub 2022 Sep 10.
8
Latexin expression is downregulated in human gastric carcinomas and exhibits tumor suppressor potential.晚期糖基化终产物受体表达下调与人类胃癌的发生、发展相关
BMC Cancer. 2011 Apr 6;11:121. doi: 10.1186/1471-2407-11-121.
9
Structure of human carboxypeptidase A4 with its endogenous protein inhibitor, latexin.人羧肽酶A4与其内源性蛋白质抑制剂——迟发性素的结构。
Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):3978-83. doi: 10.1073/pnas.0500678102. Epub 2005 Feb 28.
10
Expression of RARRES1 and AGBL2 and progression of conventional renal cell carcinoma.RARRES1 和 AGBL2 的表达与传统肾细胞癌的进展。
Br J Cancer. 2020 Jun;122(12):1818-1824. doi: 10.1038/s41416-020-0798-6. Epub 2020 Apr 20.
本文引用的文献
1
Clinical implications of AGBL2 expression and its inhibitor latexin in breast cancer.AGBL2表达及其抑制剂latexin在乳腺癌中的临床意义。
World J Surg Oncol. 2014 May 7;12:142. doi: 10.1186/1477-7819-12-142.
Zotero 插件